StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New Press Release - StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Nov 11, 2022 11:31pm

92 Views

Post# 35093208

RE:RE:RE:RE:RE:RE:New Press Release - StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

It's been over 4 months on 90k cash and a 177k raise. There has not been a PP. so either they have found internal financing or improved revenues. Either us very positive.

brad129 wrote:

Things are different now, they weren't that far from being cash positive last report. I believe they hit it now and if they did you might disappointed.

Liked2Think wrote:

be prepared for a disappointment

it's the stage way

brad129 wrote:

Cash flow positive baby, that's how come on Tripp time to show the magic.

Nailbiter2 wrote: Burning a hole in me man.

LithLover wrote: I'm curious how they ran for 4.5 months (July 1-Nov 15)
and counting on 267k cash.

PressRelease wrote:
TORONTO, ON / ACCESSWIRE / November 11, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its third quarter operational and financial results before the markets open on Tuesday, November 15, 2022. StageZero's Chairman and CEO, James...read article.